CMS Imposes Prohibition on Federal Medicaid and CHIP Payment for Certain Gender-Affirming Healthcare for Minors: What Providers Need to Know

Key Takeaways CMS has prohibited Medicaid and CHIP reimbursement for certain types of gender-affirming healthcare for minors, including puberty blockers, cross-sex hormone therapy and surgical intervention, effective October 13, 2026. The Final Rule’s prohibitions only apply if the purpose of treatment is gender-affirming healthcare. Federal funds remain available for the same drugs and therapies when … Continued